Skip to content
Screener

Twist Bioscience Corporation TWST Reportable Segment — Selling, general and administrative expenses

Similar metrics at other companies

Dollar Tree logo
DLTRReportable Segment — Selling, general and administrative expenses
$1.38B+9.0%
YSS
YSSReportable Segment — Selling, general and administrative expenses
$36.71M+37.0%
Forgent Power Solutions logo
FPSReportable Segment — Selling, general and administrative expenses
$78.52M+145%
Five Below logo
FIVEReportable Segment — Selling, general and administrative expenses
$254.91M+20.5%
Concentrix Corporation logo
CNXCReportable Segment — Selling, general and administrative expenses
$512.31M+3.5%
Black Rock Coffee Bar logo
BRCBReportable Segment — Selling, general and administrative expenses
$9.24M+34.3%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept twst:SellingGeneralAndAdministrativeExpenseExcludingDepreciationAmortizationAndShareBasedCompensationExpense.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Costs and expenses:
Cost of revenues[1]$47,402$40,373$91,408$80,744
Research and development expenses[1]17,36619,95232,71238,078
Selling, general and administrative expenses[1]59,25547,298117,03493,786
Litigation settlement costs, net of recoveries7,2057,205
Depreciation and amortization6,4146,40212,60812,784
Stock-based compensation expense18,93620,32832,20932,319
Total costs and expenses$156,578$134,353$293,176$257,711

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's reportable segment — selling, general and administrative expenses?
Twist Bioscience Corporation (TWST) reported reportable segment — selling, general and administrative expenses of $59.26M in Q1 2026.
How has Twist Bioscience Corporation's reportable segment — selling, general and administrative expenses changed year-over-year?
Twist Bioscience Corporation's reportable segment — selling, general and administrative expenses increased by 25.3% year-over-year, from $47.3M to $59.26M.
What does reportable segment — selling, general and administrative expenses mean?
Encompasses the overhead costs required to operate the reportable segment, including sales, marketing, and general administrative support. It measures the operational efficiency of the segment's support functions relative to its revenue generation.

Ask your AI about Twist Bioscience Corporation's reportable segment — selling, general and administrative expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude